Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

W, Kruis,; P, Fric,; J, Pokrotnieks,; M, Lukás,; B, Fixa,; M, Kascák,; M A, Kamm,; J, Weismueller,; C, Beglinger,; M, Stolte,; C, Wolff,; J, Schulze,

doi:10.1136/gut.2003.037747

Public

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

Published in Gut • Nov 1, 2004

Authors:

Kruis, W

Fric, P

Pokrotnieks, J

Abstract

BACKGROUND AND AIMS: Evidence exists for the pathogenic role of the enteric flora in inflammatory bowel disease. Probiotics contain living microorganisms which exert health effects on the host. We compared the efficacy in maintaining remission of the probiotic preparation Escherichia coli Nissle 191...

Subject

Adult

Aged

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!